Evidence suggests that accumulation and aggregation of α-synuclein contribute to the pathogenesis of Parkinson's disease (PD). The aim of this study was to evaluate whether diffusion kurtosis imaging (DKI) will provide a sensitive tool for differentiating between α-synuclein-overexpressing transgenic mouse model of PD (TNWT-61) and wild-type (WT) littermates. This experiment was designed as a proof-of-concept study and forms a part of a complex protocol and ongoing translational research. Nine-month-old TNWT-61 mice and age-matched WT littermates underwent behavioral tests to monitor motor impairment and MRI scanning using 9.4 Tesla system in vivo. Tract-based spatial statistics (TBSS) and the DKI protocol were used to compare the whole brain white matter of TNWT-61 and WT mice. In addition, region of interest (ROI) analysis was performed in gray matter regions such as substantia nigra, striatum, hippocampus, sensorimotor cortex, and thalamus known to show higher accumulation of α-synuclein. For the ROI analysis, both DKI (6 b-values) protocol and conventional (2 b-values) diffusion tensor imaging (cDTI) protocol were used. TNWT-61 mice showed significant impairment of motor coordination. With the DKI protocol, mean, axial, and radial kurtosis were found to be significantly elevated, whereas mean and radial diffusivity were decreased in the TNWT-61 group compared to that in the WT controls with both TBSS and ROI analysis. With the cDTI protocol, the ROI analysis showed decrease in all diffusivity parameters in TNWT-61 mice. The current study provides evidence that DKI by providing both kurtosis and diffusivity parameters gives unique information that is complementary to cDTI for in vivo detection of pathological changes that underlie PD-like symptomatology in TNWT-61 mouse model of PD. This result is a crucial step in search for a candidate diagnostic biomarker with translational potential and relevance for human studies.

Applied Neuroscience Research Group CEITEC Central European Institute of Technology Masaryk University Kamenice 5 625 00 Brno Czech Republic

Department of Neurology Faculty of Medicine Albert Szent Györgyi Clinical Centre University of Szeged Szeged Hungary

Department of Pharmacology Faculty of Medicine Masaryk University Brno Czech Republic

Experimental and Applied Neuropsychopharmacology Group CEITEC Central European Institute of Technology Masaryk University Brno Czech Republic

Institute of Scientific Instruments Academy of Sciences of the Czech Republic Brno Czech Republic

Multimodal and Functional Imaging Laboratory CEITEC Central European Institute of Technology Masaryk University Brno Czech Republic

NeuroScios GmbH Graz Austria

QPS Austria GmbH Grambach Austria

Zobrazit více v PubMed

Neuroimage Clin. 2013 Oct 14;3:481-8 PubMed

Radiology. 2012 Nov;265(2):645-6; author reply 646-7 PubMed

PLoS One. 2013;8(3):e59032 PubMed

Neuroimage. 2004;23 Suppl 1:S208-19 PubMed

Mov Disord. 2011 May;26(6):1072-82 PubMed

NeuroRx. 2005 Jul;2(3):495-503 PubMed

Stroke. 2012 Aug;43(8):2252-4 PubMed

Magn Reson Med. 2005 Jun;53(6):1432-40 PubMed

J Neurosci. 2004 Oct 20;24(42):9434-40 PubMed

NMR Biomed. 2014 Aug;27(8):948-57 PubMed

Eur J Neurosci. 2011 Apr;33(8):1551-60 PubMed

AJR Am J Roentgenol. 2014 Jan;202(1):W26-33 PubMed

Biol Psychiatry. 2011 Sep 1;70(5):449-57 PubMed

Neurology. 2009 Apr 21;72(16):1374-5 PubMed

Neuroimage. 2012 Jan 2;59(1):467-77 PubMed

Magn Reson Med. 1996 Dec;36(6):893-906 PubMed

NMR Biomed. 2010 Aug;23(7):698-710 PubMed

Magn Reson Med. 2013 Apr;69(4):1115-21 PubMed

J Neurol. 2011 Jul;258(7):1254-60 PubMed

Neurology. 2013 Feb 26;80(9):857-64 PubMed

J Neurosci Methods. 2003 Mar 15;123(2):189-200 PubMed

Neurotox Res. 2011 Aug;20(2):170-81 PubMed

Neuroimage. 2006 Jul 15;31(4):1487-505 PubMed

Front Biosci (Elite Ed). 2014 Jun 01;6:360-9 PubMed

Neurotherapeutics. 2012 Apr;9(2):297-314 PubMed

Neurobiol Dis. 2007 Jun;26(3):590-6 PubMed

Neuroscience. 2006 Nov 3;142(4):1245-53 PubMed

Magn Reson Imaging. 2013 Nov;31(9):1501-6 PubMed

Neurotox Res. 2009 Aug;16(2):127-39 PubMed

Neuroimage. 2012 Nov 1;63(2):653-62 PubMed

Neuroradiology. 2014 Mar;56(3):251-8 PubMed

Radiology. 2011 Oct;261(1):210-7 PubMed

World Neurosurg. 2014 Jul-Aug;82(1-2):96-109 PubMed

Neurology. 2009 Apr 21;72(16):1378-84 PubMed

Hum Brain Mapp. 2002 Nov;17(3):143-55 PubMed

Brain Struct Funct. 2011 Jun;216(2):123-35 PubMed

Brain Res. 2012 Apr 27;1451:100-9 PubMed

Exp Neurol. 2008 Jan;209(1):22-7 PubMed

Mov Disord. 2013 Jan;28(1):3-7 PubMed

Neuroscience. 2014 Sep 26;277:647-64 PubMed

Exp Neurol. 2012 Oct;237(2):318-34 PubMed

Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease

Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease